COMMUNIQUÉ DE PRESSE

par MEDIQON Group AG (isin : DE0006618309)

Capital Increase against contribution in kind from Authorized Capital resolved

EQS-News: CHAPTERS Group AG / Key word(s): Corporate Action
Capital Increase against contribution in kind from Authorized Capital resolved

25.01.2024 / 20:07 CET/CEST
The issuer is solely responsible for the content of this announcement.


As announced in the ad-hoc release of January 25, 2024, the Management Board (with the approval of the Supervisory Board) of CHAPTERS Group AG (ISIN: DE0006618309) resolved a capital increase against contribution in kind from authorized capital with the exclusion of subscription rights by issuing new shares in the amount of approx. 7.7% of the share capital.

An amount of 587,911 in new shares will be issued to the management team of Fintiba GmbH. In December 2023, CHAPTERS Group AG acquired an additional 15.1% of the shares held by the management team in Fintiba GmbH resulting in an overall ownership of 55% in the company. The consideration was partially paid in cash with the remainder being deferred as a seller loan which will now be contributed in kind. 

CEO Jan Mohr: “We have been a shareholder of Fintiba GmbH since May 2021. The company has demonstrated impressive growth over the past three years and we are very excited that we were able to increase our share once again from 39.9% to now 55%. The management team of Fintiba has done an outstanding job in developing the company and we are looking forward to accompanying the growth over the next decades. We are very happy that the management team decided to contribute the seller loan in kind against CHAPTERS Group shares to participate in the long-term value creation at Fintiba and CHAPTERS Group.”

In addition, an amount of 810,602 in new shares will be issued against a contribution of shares in Software Circle plc by several existing shareholders of Software Circle plc.

Jan Mohr adds “As chairman of the board at Software Circle plc, I have accompanied the evolution of Software Circle plc into a serial acquirer of great vertical market software businesses over the past years. The team has truly transformed the company and is building a home for these businesses in the UK and Ireland. With a recent capital increase and a well-filled pipeline of additional acquisition targets, Software Circle is poised to accelerate its ambitions. CHAPTERS Group has been a minority shareholder since last year and we are very excited to increase our stake to c. 29.9% and become the largest shareholder. Software Circle plc is a fantastic addition to our existing platforms and helps us to execute on our ambition to become the best home for mission critical businesses in Europe.”

The shares in Software Circle plc have been valued at GPB 0.138 per share, in line with the current stock price.

The new shares by CHAPTERS Group AG will be issued for a price of EUR 17.61 per share, in line with the most recent capital increase placed in December 2023.

The capital increase against contribution in kind will be published in the German “Bundesanzeiger” within the next days. Registration of the new shares is expected for beginning of March 2024.



25.01.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language:English
Company:CHAPTERS Group AG
Falkenried 29
20251 Hamburg
Germany
Phone:+ 49 (0) 40 / 20 95 02 69
Fax:+ 49 (0) 40 / 20 96 87 92
E-mail:ir@chaptersgroup.com
Internet:www.chaptersgroup.com
ISIN:DE0006618309, DE000A254TL0
WKN:661830, A254TL
Listed:Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate Exchange
EQS News ID:1823387

 
End of NewsEQS News Service

1823387  25.01.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1823387&application_name=news&site_id=symex
Voir toutes les actualités de MEDIQON Group AG